627 results on '"Berraondo, Pedro"'
Search Results
2. Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma
3. mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
4. Intratumoral administration of mRNA encoding IL-12-based immunocytokines targeting CSF1R and PD-L1 exert potent antitumor effects while restraining systemic exposure to IL-12
5. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists and TGF-β antagonists.
6. Charting roadmaps towards novel and safe synergistic immunotherapy combinations
7. A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes
8. Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps
9. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment
10. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
11. The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapy
12. Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases
13. Overcoming the limitations of cytokines to improve cancer therapy
14. Opportunities and challenges of bi-specific antibodies
15. Omentum: Friend or foe in ovarian cancer immunotherapy?
16. Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
17. Unveiling the multifaceted antitumor effects of interleukin 33.
18. Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
19. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials
20. Interleukin-18 in cancer immunology and immunotherapy
21. The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
22. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis
23. CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
24. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
25. Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
26. A new immune-nanoplatform for promoting adaptive antitumor immune response
27. Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
28. Druggable Targets in Cytokine Release Syndromes
29. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects
30. Production and use of adeno-associated virus vectors as tools for cancer immunotherapy
31. Rapid isolation and enrichment of mouse NK cells for experimental purposes
32. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
33. Cytokines in clinical cancer immunotherapy
34. Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
35. International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
36. Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
37. Silver nanoparticles induce a non-immunogenic tumor cell death.
38. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
39. Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
40. Supplementary Figures from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
41. Supplementary Data from Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
42. Supplementary Figure from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
43. Data from Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
44. Data from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
45. Abstract 614: CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects
46. Supplementary Tables from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
47. Data from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
48. Supplementary figure 3 from TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
49. Supplementary figure 2 from TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
50. Data from TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.